ADC Therapeutics Cash from Investing (TTM) Analysis

ADC Therapeutics SA (ADCT)

4.70 +0.29 (+6.58%) USD | NYSE | May 01, 16:00

4.70 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-3.216M
September 30, 2023	-0.985M
June 30, 2023	-0.578M
March 31, 2023	-0.255M
December 31, 2022	-0.687M
September 30, 2022	-3.221M
June 30, 2022	-5.305M

Date	Value
March 31, 2022	-7.464M
December 31, 2021	-6.673M
September 30, 2021	-6.636M
June 30, 2021	-5.699M
March 31, 2021	-2.989M
December 31, 2020	-2.828M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-7.464M

Minimum

Mar 2022

-0.255M

Maximum

Mar 2023

-3.580M

Average

-3.216M

Median

Dec 2023

Cash from Investing (TTM) Benchmarks